Clinical-and-economical analysis of modern bronchial asthma management under a local antiasthmatic programme
Abstract
The aim of this study was to define full cost of therapy of adult bronchial asthma (BA) taking into account BA spread in Lesnoy and to evaluate economical benefit of modern BA management using the cost-benefit and cost-effectiveness analyses.
The investigation was performed in Lesnoy town of Sverdlovsk region having 46,500 adult residents and BA spread 5.7% (the patients' age was 18 to 74 yrs). Three hundred and fifty three BA patients were registered in 1999 and 636 were in 2002 when seeking the aid. A list of antiasthmatic medications was determined including domestic drugs: Benacort, Salben, Saltos, Salgim. Sixty four per cent of the BA patients registered received the basic therapy with the domestic medications. The clinical-and-economical investigation used methods detecting full cost of the disease and cost-benefit and cost-effectiveness analysis.
The results allowed to define the full cost of BA in Lesnoy which was 625,672 USD, or 13 USD for every resident of the town and 237 USD for every BA patient annually. The structural analysis of the BA cost showed a prevalence of direct (59%) expenses compared with the indirect ones (41%). Among the direct expenses the inpatient treatment (63%) and medication (27%) costs predominated. Manufacture waste (45%) prevailed in the indirect expenses. This analysis demonstrated a significant decrease (in near 2 times) in the direct and indirect expenses resulted from application of the modern methods of the BA management with the domestic medications. An economic efficiency of the domestic drug Benacort was showed which decreased the cost-benefit ratio in 6 times.
The application of the modern management of the registered BA patients diminished the cost-effectiveness ratio in more than 2 times.
So, the clinical-and-economical study of the modern BA management efficiency under the local antiasthmatic programme analyzed the full cost of the disease, the cost-benefit and the cost-effectiveness ratio and allowed to determine the BA expenditure in Lesnoy; it showed the economical effect of the domestic antiasthmatic medications and of the new approach to the cost-effectiveness of the modern BA management.
About the Author
E. K. Beltyukov
Свердловская областная клиническая больница №1;
Центральная медико-санитарная часть № 91
Russian Federation
Russian Federation
References
1. Экономическая оценка эффективности лекарственной терапии (фармакоэкономический анализ) / Аксентьева М.В., Воробьев П.А., Герасимов В.Б. и др. М.: Ныодиамед; 2000.
2. Бримкулов H.H., Jones Р. W., Калиева Л.Д. Валидизация русской версии краткого опросника AQ20 для исследования качества жизни у больных астмой. Пульмонология 1993; 3: 14-20.
3. Ермаков B.C., Соколов A.C., Корчагин В.П. Фармакоэкономическая эффективность применения отечественных противоастматических препаратов в лечении больных бронхиальной астмой: Метод, рекомендации / Под ред. А.Г.Чучалина. М.; 1997.
4. Медников B.Л. Экономические аспекты в пульмонологии. В кн.: Чучалин А.Г. (ред.) Бронхиальная астма. М.: Агар; 1997; т.1: гл. 14. 501-509.
5. Огородова Л.М., Ленская Л.Г., Абазова Ф.И. и др. Оптимизация лечения больных как результат реализации антиастматической программы в Томской области. Вести, межрегион. ассоц. "Здравоохр. Сибири" 2001; 2: 14-16.
6. Просекова Е.В. Иммунотропная терапия при бронхиальной астме у детей и ее фармакоэкономическая оценка: Автореф. дис. ... д-ра мед. наук. 2000.
7. Пунин A.A., Старовойтов В.И., Ковалева С.В. и др. Итоги реализации положений GINA в практическое здравоохранение. Пульмонология 2001; 3: 69-72.
8. Федосеева Л.С. Медико-экономическая эффективность оказания лечебной помощи больным бронхиальной астмой в амбулаторно-поликлинических условиях: Автореф. дис. ... канд. мед. наук. 2001.
9. Чучалин А.Г., Пыжева Е.С., Колганова H.A. Социально-экономическая значимость заболеваемости бронхиальной астмой и ее стоимостное определение. Экономика здравоохр. 1997; 4: 29-37.
10. Чучалин А.Г. (ред.) Глобальная стратегия лечения и профилактики бронхиальной астмы. М.: Атмосфера; 2002.
11. Global initiative for asthma. Global strategy for asthma management and prevention. Publ. N 45-3659. Washington: National Heart, Lung and Blood Institute, National Institutes of Health; 1995
Review
For citations:
Beltyukov E.K. Clinical-and-economical analysis of modern bronchial asthma management under a local antiasthmatic programme. PULMONOLOGIYA. 2003;(1):83-89. (In Russ.)
Views:
238
Email this article 